Page last updated: 2024-10-28

hexamethonium and Abscess

hexamethonium has been researched along with Abscess in 1 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Abscess: Accumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
OHYAMA, Y1
AOKI, Y1
TAMURA, K1
KAWABE, A1
IMAI, T1
KIKUTA, R1
EGUCHI, A1
MASHIMA, T1
OGURO, C1

Other Studies

1 other study available for hexamethonium and Abscess

ArticleYear
A CASE OF ACUTE MYOCARDIAL INFARCTION WITH INITIAL ST SEGMENT DEPRESSIN.
    Japanese circulation journal, 1964, Volume: 28

    Topics: Abscess; Alanine Transaminase; Anal Canal; Arrhythmias, Cardiac; Aspartate Aminotransferases; Blood

1964